FOR RESEARCH USE ONLY. The content provided in this article is for educational and informational purposes only and is based on published scientific literature. The compounds discussed are not approved by the FDA for human or veterinary use. They are strictly intended for laboratory research and in vitro experimentation. Pure Health Peptides does not endorse or encourage the use of these products outside of a controlled research setting.
Snap-8, known chemically as Acetyl Octapeptide-3, is a synthetic octapeptide studied for a single, well-defined molecular property: it is designed to mimic a segment of the SNAP-25 protein and, in that role, to interfere with the assembly of the SNARE complex that drives vesicle fusion. That mechanism is what places Snap-8 in dermal and neuromuscular-signaling research.
This article describes the structure of Snap-8, the SNAP-25 mimicry and SNARE-complex research behind it, its place in dermal research, and how the compound is verified as research material.
Research Snapshot
- Snap-8 is a synthetic octapeptide, Acetyl Octapeptide-3, with the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2. Its molecular formula is C42H72N16O15S and its molecular weight is approximately 1,075.3 g/mol.
- It is an extension of the shorter acetyl hexapeptide sequence, adding two residues, and it is designed to mimic the N-terminal segment of the SNAP-25 protein.
- In vitro research on this class of peptides reports that a SNAP-25-mimetic sequence can competitively interfere with the assembly of the SNARE complex, the protein machinery that mediates vesicle docking and fusion (Blanes-Mira et al., 2002; Gutiérrez et al., 2003).
- The SNARE complex governs regulated exocytosis, so a peptide that interferes with its assembly is studied in neuromuscular-signaling and dermal-research contexts, in preclinical and in vitro systems.
- Pure Health Peptides supplies Snap-8 as a lyophilized Vial (Acetyl Octapeptide-3), part of the broader catalog. Every lot is finished and tested in the USA, routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics as the exclusive testing partner.
Introduction
Snap-8 belongs to a small group of peptides defined not by a receptor they bind but by a protein interaction they disrupt. The SNARE complex is a piece of cellular machinery responsible for fusing vesicles with the cell membrane, a step required for regulated secretion, and the SNAP-25 protein is one of its core components. Snap-8 is engineered to imitate part of SNAP-25, and the research interest in it follows from what that imitation does: it competes with the real protein and interferes with the complex assembling correctly.
This article keeps to that mechanism and the research built on it. It describes the octapeptide structure, the SNAP-25 mimicry and SNARE-complex research that defines the peptide, and the dermal-research context in which it is studied, all in preclinical and in vitro terms. It stays within the research-use framing and does not extend to any applied use.
Snap-8 Structure: Acetyl Octapeptide-3
Structurally, Snap-8 is a short, defined synthetic peptide. Its sequence, Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2, is an octapeptide, eight residues, capped with an N-terminal acetyl group and a C-terminal amide, the same terminal modifications used across many synthetic research peptides to improve stability. It has the molecular formula C42H72N16O15S and a molecular weight of approximately 1,075.3 g/mol.
The sequence is a deliberate extension. Snap-8 adds two residues to a shorter acetyl hexapeptide, and both are built to reproduce the N-terminal region of the SNAP-25 protein. Because the peptide is a defined synthetic sequence, its identity is straightforward to confirm by mass spectrometry against the theoretical mass, which is the basis of lot-level verification.
SNAP-25 Mimicry and SNARE Complex Research
The mechanism that defines Snap-8 is molecular mimicry. SNAP-25 is one of the three core proteins of the SNARE complex, which brings a vesicle and the target membrane together so they can fuse, the final step in regulated exocytosis. By reproducing a segment of SNAP-25, a mimetic peptide can insert itself into that process and compete with the genuine protein, interfering with the complex assembling into its functional form.
The research literature on this peptide class describes exactly that behavior. Studies of SNAP-25-derived peptides report that they can inhibit the docking and fusion of secretory vesicles by disrupting SNARE complex formation in vitro (Gutiérrez et al., 2003), and the specific hexapeptide from which Snap-8 is extended was characterized as a SNAP-25 N-terminal mimic that destabilizes the complex (Blanes-Mira et al., 2002).
Because the SNARE complex underlies neurotransmitter and secretory-vesicle release, this competitive interference is the mechanistic basis for studying the peptide in neuromuscular-signaling contexts, always in the preclinical and in vitro terms the literature uses.
Dermal Research and the Topical Systems Context
Snap-8 sits within dermal research, and its relevance there follows from the same SNARE mechanism rather than from any applied outcome. Peptides that modulate SNARE-mediated signaling are studied in dermal and fibroblast research models, and Snap-8 is examined in that context as a defined SNARE-mimetic tool. The appropriate framing is the molecular interaction under study, not any applied result.
In the Pure Health Peptides catalog, Snap-8 also appears as one of the compositions in the Pure Topical Research System, specifically in Topical System E, which situates it within the Topical Systems research line introduced earlier in the year. The standalone research material, however, is supplied as a lyophilized vial. For the broader dermal-research context, the GHK-Cu article covers a different dermal-signaling peptide, and the two sit alongside each other in the dermal cluster.
Verification
Underneath the compound is the verification chain. Pure Health Peptides does not manufacture the material; production is sourced from qualified third-party manufacturers, and the material is finished and tested in the USA.
Every lot is routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics as the exclusive testing partner, and each qualified lot’s Certificate of Analysis is published in the COA Library, in the vial section, retrievable by batch ID.
For a lyophilized vialed peptide, the appropriate panel extends beyond identity, purity, and quantity to include endotoxin and microbial limits, because contamination can enter downstream of synthesis through handling, lyophilization, vial filling, storage, and transit.
The Testing Process page documents how that verification runs, and the Manufacturing Process page covers where the material comes from.
Where Snap-8 Sits in Dermal and SNARE Research
For researchers studying SNARE-mediated signaling, Snap-8 is a defined, well-characterized SNAP-25-mimetic peptide, a specific molecular tool for probing what happens when the SNARE complex is competitively interfered with. Its research value rests on that mechanism: a short synthetic sequence engineered to imitate part of a core fusion protein.
As research on SNARE biology and dermal signaling continues, mimetic peptides like Snap-8 remain useful reference tools, and the compound holds a specific place in both the dermal cluster and the Topical Systems research line.
Frequently Asked Questions
What is Snap-8?
Snap-8 is a synthetic octapeptide, known chemically as Acetyl Octapeptide-3, with the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2. Its molecular formula is C42H72N16O15S and its molecular weight is approximately 1,075.3 g/mol.
What is Snap-8 studied for in research?
It is studied for its designed mimicry of the SNAP-25 protein and its reported ability, in vitro, to competitively interfere with the assembly of the SNARE complex that mediates vesicle fusion. These are research findings in preclinical and in vitro systems.
What is the SNARE complex?
The SNARE complex is the protein machinery that brings a vesicle and the target membrane together so they can fuse, the step required for regulated secretion. SNAP-25 is one of its core proteins, and Snap-8 is designed to mimic part of it.
How does Snap-8 relate to the Topical Systems line?
Snap-8 is one of the compositions in Topical System E within the Pure Topical Research System. The standalone research material is supplied separately as a lyophilized vial.
What carrier format is Snap-8 available in, and how is it verified?
A lyophilized vial. Every lot is finished and tested in the USA and routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics, with a lot-specific Certificate of Analysis published in the COA Library.
References
- Blanes-Mira C, et al. A synthetic hexapeptide with antiwrinkle activity. International Journal of Cosmetic Science, 2002;24(5):303-310. https://doi.org/10.1046/j.1467-2494.2002.00153.x
- Gutiérrez LM, et al. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25. Journal of Protein Chemistry, 2003. https://pubmed.ncbi.nlm.nih.gov/12760419/
- Gutiérrez LM, et al. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. FEBS Letters, 1997. https://pubmed.ncbi.nlm.nih.gov/9006897/
- International Organization for Standardization / International Electrotechnical Commission. ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories. https://www.iso.org/standard/66912.html
